Understand how metabolic-bariatric surgery reduces pancreatic cancer risk in obese diabetic patients, offering a significant ...

“Neoadjuvant chemotherapy is what we term for individuals that need chemotherapy prior to surgery,” said Philip Kovoor, MD, ...

Katherine A. Morgan, MD, recognized internationally for her expertise in pancreatic surgery, is joining NYU Langone Health as a professor in the Department of Surgery and as section chief of pancreas ...

For individuals with obesity, metabolic-bariatric surgery (MBS) is associated with a reduced risk for pancreatic cancer.

Obesity and type 2 diabetes are risk factors for various malignancies, including pancreatic cancer, which has a high death ...

Metabolic-bariatric surgery (MBS) appears to lower the risk for pancreatic cancer in people with obesity, with a potentially ...

Organ transplant surgery has also decreased significantly this year compared to last year due to prolonged medical gaps ...

Northwestern Medicine investigators have discovered that a novel combination therapy promotes cancer cell death and tumor ...

Reduced risk was more pronounced in those with type 2 diabetes, but was also seen in those without T2D. HealthDay News — For individuals with obesity, metabolic-bariatric surgery (MBS) is ...

RNA vaccines have gained widespread attention for their crucial role in fighting the COVID-19 pandemic. Yet, even before the ...

Regular aspirin use significantly lowers the risk of developing pancreatic cancer, a study has found. Research funded by PLANETS Cancer Charity and carried out by University Hospital Southampton and ...